Glyko Biomedical Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 2

Glyko Biomedical General Information

Description

Provider of biomedical research services. The company provides scientific research services regarding biotechnology and pharmaceuticals.

Contact Information

Website
www.glyko.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 371 Bel Marin Keys Boulevard
  • Suite 210
  • Novato, CA 94949
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 371 Bel Marin Keys Boulevard
  • Suite 210
  • Novato, CA 94949
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glyko Biomedical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Glyko Biomedical‘s full profile, request access.

Request a free trial

Glyko Biomedical Patents

Glyko Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-5283450-A Fit-ccd image sensing device Inactive 15-Apr-1991
CA-1233827-A Halogenated hydantoins Inactive 11-Sep-1984
CA-1214373-A Agglomerated halo-hydantoins Inactive 18-Oct-1983
US-4481038-A Lubricant waxes Inactive 29-Jun-1983
US-4363891-A Glyceryl monostearate plastic lubricants Inactive 14-May-1981 C08K5/103
To view Glyko Biomedical’s complete patent history, request access »

Glyko Biomedical Investments (2)

Glyko Biomedical’s most recent deal was a PE Growth/Expansion with BioMarin Pharmaceutical for . The deal was made on 15-Jul-1998.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BioMarin Pharmaceutical 15-Jul-1998 PE Growth/Expansion Drug Discovery
BioMarin Pharmaceutical 01-Mar-1997 Seed Round Drug Discovery
To view Glyko Biomedical’s complete investments history, request access »

Glyko Biomedical Exits (2)

Glyko Biomedical’s most recent exit was on 15-Jul-1998 from BioMarin Pharmaceutical. The exit was categorized as with 5 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
BioMarin Pharmaceutical 15-Jul-1998 Completed
  • 5 buyers
BioMarin Pharmaceutical 01-Mar-1997 Seed Round Completed
  • 3 buyers
To view Glyko Biomedical’s complete exits history, request access »

Glyko Biomedical FAQs

  • When was Glyko Biomedical founded?

    Glyko Biomedical was founded in 1992.

  • Where is Glyko Biomedical headquartered?

    Glyko Biomedical is headquartered in Novato, CA.

  • What industry is Glyko Biomedical in?

    Glyko Biomedical’s primary industry is Drug Discovery.

  • Is Glyko Biomedical a private or public company?

    Glyko Biomedical is a Private company.

  • What is the current valuation of Glyko Biomedical?

    The current valuation of Glyko Biomedical is .

  • What is Glyko Biomedical’s current revenue?

    The current revenue for Glyko Biomedical is .

  • When was Glyko Biomedical acquired?

    Glyko Biomedical was acquired on 22-Aug-2002.

  • Who acquired Glyko Biomedical?

    Glyko Biomedical was acquired by BioMarin Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process